CLINICAL_TRIALS
trial_result
· 2022-05-05
Clinical Trial Update: Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee [Phase 3]
Summary
Phase 3 clinical trial update for YYC301 in knee osteoarthritis; current status is UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Osteoarthritis, Knee | Phase 3 | Status: UNKNOWN